Abstract
Purpose
To systematically analyse randomised controlled trials (RCTs) about efficacy and safety of proliferative injection therapy (prolotherapy) for treatment of osteoarthritis (OA).
Methods
CENTRAL, Embase and MEDLINE were searched. Two reviewers independently conducted screening and data extraction. RCTs were assessed with the Cochrane risk of bias tool. Type of treatment, study design, dosing, efficacy outcomes and safety outcomes were analysed. The protocol was registered in PROSPERO (CRD42016035258).
Results
Seven RCTs were included, with 393 participants aged 40-75 years and mean OA pain duration from three months to eight years. Follow-up was 12 weeks to 12 months. Studies analysed OA of the knee joint (n = 5), first carpometacarpal joint (n = 1) and finger joints (n = 1). Various types of prolotherapy were used; dextrose was the most commonly used irritant agent. All studies concluded that prolotherapy was effective treatment for OA. No serious adverse events were reported. The studies had considerable methodological limitations.
Discussion
Limited evidence from low-quality studies indicates a beneficial effect of prolotherapy for OA management. The number of participants in these studies was too small to provide reliable evidence.
Conclusions
Current data from trials about prolotherapy for OA should be considered preliminary, and future high-quality trials on this topic are warranted.
Similar content being viewed by others
References
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1323–1330. doi:10.1136/annrheumdis-2013-204763
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P (2012) American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res 64(4):465–474. doi:10.1002/acr.21596
Richter M, Trzeciak T, Owecki M, Pucher A, Kaczmarczyk J (2015) The role of adipocytokines in the pathogenesis of knee joint osteoarthritis. Int Orthop 39(6):1211–1217. doi:10.1007/s00264-015-2707-9
De Filippis L, Gulli S, Caliri A, Romano C, Munao F, Trimarchi G, La Torre D, Fichera C, Pappalardo A, Triolo G, Gallo M, Valentini G, Bagnato G (2004) Epidemiology and risk factors in osteoarthritis: literature review data from “OASIS” study. Reumatismo 56(3):169–184. doi:10.4081/reumatismo.2004.169
Glyn-Jones S, Palmer AJ, Agricola R, Price AJ, Vincent TL, Weinans H, Carr AJ (2015) Osteoarthritis. Lancet 386(9991):376–387. doi:10.1016/S0140-6736(14)60802-3
Samson DJ, Grant MD, Ratko TA, Bonnell CJ, Ziegler KM, Aronson N (2007) Treatment of primary and secondary osteoarthritis of the knee. Evid Rep Technol Assess 157:1–157
Conaghan PG (2013) Osteoarthritis in 2012: parallel evolution of OA phenotypes and therapies. Nat Rev Rheumatol 9(2):68–70. doi:10.1038/nrrheum.2012.225
Tucker JD, Ericksen JJ, Goetz LL, Elmore LW (2014) Should clinical studies involving “regenerative injection therapy,” strive to incorporate a triad of outcome measures instead of only including clinical outcome measures? Osteoarthr Cartil 22(6):715–717. doi:10.1016/j.joca.2014.04.005
Trzeciak T, Richter M, Suchorska W, Augustyniak E, Lach M, Kaczmarek M, Kaczmarczyk J (2016) Application of cell and biomaterial-based tissue engineering methods in the treatment of cartilage, menisci and ligament injuries. Int Orthop 40(3):615–624. doi:10.1007/s00264-015-3099-6
Distel LM, Best TM (2011) Prolotherapy: a clinical review of its role in treating chronic musculoskeletal pain. PM R 3(6 Suppl 1):S78–S81. doi:10.1016/j.pmrj.2011.04.003
Vora A, Borg-Stein J, Nguyen RT (2012) Regenerative injection therapy for osteoarthritis: fundamental concepts and evidence-based review. PM R 4(5 Suppl):S104–S109. doi:10.1016/j.pmrj.2012.02.005
Linetsky FS, Miguel R, Torres F (2004) Treatment of cervicothoracic pain and cervicogenic headaches with regenerative injection therapy. Curr Pain Headache Rep 8(1):41–48. doi:10.1007/s11916-004-0039-3
Jensen KT, Rabago DP, Best TM, Patterson JJ, Vanderby R Jr (2008) Early inflammatory response of knee ligaments to prolotherapy in a rat model. J Orthop Res 26(6):816–823. doi:10.1002/jor.20600
Yelland MJ, Glasziou PP, Bogduk N, Schluter PJ, McKernon M (2004) Prolotherapy injections, saline injections, and exercises for chronic low-back pain: a randomized trial. Spine 29(1):9–16. doi:10.1097/01.BRS.0000105529.07222.5B, discussion 16
Covey CJ, Sineath MH Jr, Penta JF, Leggit JC (2015) Prolotherapy: can it help your patient? J Fam Pract 64(12):763–768
Kim WM, Lee HG, Jeong CW, Kim CM, Yoon MH (2010) A randomized controlled trial of intra-articular prolotherapy versus steroid injection for sacroiliac joint pain. J Altern Complement Med 16(12):1285–1290. doi:10.1089/acm.2010.0031
Bertrand H, Reeves KD, Bennett CJ, Bicknell S, Cheng A-L (2016) Dextrose prolotherapy versus control injections in painful rotator cuff tendinopathy. Arch Phys Med Rehabil 97(1):17–25. doi:10.1016/j.apmr.2015.08.412
Rabago D, Slattengren A, Zgierska A (2010) Prolotherapy in primary care practice. Prim Care 37(1):65–80. doi:10.1016/j.pop.2009.09.013
Rabago D, Best TM, Beamsley M, Patterson J (2005) A systematic review of prolotherapy for chronic musculoskeletal pain. Clin J Sport Med 15(5):376–380. doi:10.1097/01.jsm.0000173268.05318.a4
Rahimzadeh P, Imani F, Faiz SHR, Entezary SR, Nasiri AA, Ziaeefard M (2014) Investigation the efficacy of intra-articular prolotherapy with erythropoietin and dextrose and intra-articular pulsed radiofrequency on pain level reduction and range of motion improvement in primary osteoarthritis of knee. J Res Med Sci 8:696–702
Jahangiri A, Moghaddam FR, Najafi S (2014) Hypertonic dextrose versus corticosteroid local injection for the treatment of osteoarthritis in the first carpometacarpal joint: a double-blind randomized clinical trial. J Orthop Sci 5:737–743. doi:10.1007/s00776-014-0587-2
Eslamian F, Amouzandeh B (2015) Therapeutic effects of prolotherapy with intra-articular dextrose injection in patients with moderate knee osteoarthritis: a single-arm study with 6 months follow up. Ther Adv Musculoskelet Dis 7(2):35–44. doi:10.1177/1759720X14566618
Reeves KD, Hassanein K (2000) Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Altern Ther Health Med (2):68–74, 77–80
Reeves KD, Hassanein K (2000) Randomized, prospective, placebo-controlled double-blind study of dextrose prolotherapy for osteoarthritic thumb and finger (DIP, PIP, and trapeziometacarpal) joints: evidence of clinical efficacy. J Altern Complement Med 6(4):311–320. doi:10.1089/10755530050120673
Dumais R, Benoit C, Dumais A, Babin L, Bordage R, Arcos C, Allard J, Bélanger M (2012) Effect of regenerative injection therapy on function and pain in patients with knee osteoarthritis: a randomized crossover study. Pain Med 8:990–999. doi:10.1111/j.1526-4637.2012.01422.x
Hashemi M, Jalili P, Mennati S, Koosha A, Rohanifar R, Madadi F, Razavi SS, Taheri F (2015) The effects of prolotherapy with hypertonic dextrose versus prolozone (intraarticular ozone) in patients with knee osteoarthritis. Anesth Pain Med (5). doi:10.5812/aapm.27585
Hashemi SM, Madadi F, Razavi S, Nikooseresht M, Kiyabi FH, Nasiripour S (2012) Intra-articular hyaluronic acid injections vs. dextrose prolotherapy in the treatment of osteoarthritic knee pain. Tehran Univ Med J (2):119–125
Sit RW, Chung VC, Reeves KD, Rabago D, Chan KK, Chan DC, Wu X, Ho RS, Wong SY (2016) Hypertonic dextrose injections (prolotherapy) in the treatment of symptomatic knee osteoarthritis: a systematic review and meta-analysis. Sci Rep 6:25247. doi:10.1038/srep25247
Dagenais S, Yelland MJ, Del Mar C, Schoene ML (2007) Prolotherapy injections for chronic low-back pain. Cochrane Database Syst Rev 2, CD004059. doi:10.1002/14651858.CD004059.pub3
Roberts I, Ker K (2015) How systematic reviews cause research waste. Lancet 386(10003):1536. doi:10.1016/S0140-6736(15)00489-4
Handoll HHG, Langhorne P (2015) In defence of reviews of small trials: underpinning the generation of evidence to inform practice. Cochrane Database Syst Rev 11, ED000106. doi:10.1002/14651858.ED000106
Mooney V (2003) Prolotherapy at the fringe of medical care, or is it the frontier? Spine J 3(4):253–254. doi:10.1016/S1529-9430(03)00063-9
Yentur EA, Okcu G, Yegul I (2003) The role of trigger point therapy in knee osteoarthritis. Pain Clin 15(4):385–390. doi:10.1163/156856903770196746
Lee JH, Lee SH, Song SH (2010) Clinical effectiveness of botulinum toxin A compared to a mixture of steroid and local anesthetics as a treatment for sacroiliac joint pain. Pain Med 11(5):692–700. doi:10.1111/j.1526-4637.2010.00838.x
Berenfeld A, Bessing WD, Bisplinghoff U, Bittner G, Matthiesen HO, Tilscher H, Ramm S, Ebeling L, Schmitz H (1991) [Gonalgia: treatment with therapeutic local anesthesia. Results of a controlled comparative study versus diclofenac]. Fortschritte der Medizin (35):724–728
Down S, Waddington G, Adams R, Thomson M (2007) Movement discrimination after intra-articular local anaesthetic of the ankle joint. Br J Sports Med 8:501–505. doi:10.1136/bjsm.2006.031468
Gu ZY, Wu HL, Wu QL, Cao ZQ, Zhang YX (1998) The effect of intra-articular irrigation injection therapy on osteoarthrosis of the temporomandibular joint. Chin J Dent Med 3:44–48
Kim K-H, Choi S-H, Kim T-K, Shin S-W, Kim C-H, Kim J-I (2005) Cervical facet joint injections in the neck and shoulder pain. J Korean Med Sci 20(4):659–662. doi:10.3346/jkms.2005.20.4.659
Kopp S, Wenneberg B (1981) Effects of occlusal treatment and intraarticular injections on temporomandibular joint pain and dysfunction. Acta Odontol Scand 2:87–96. doi:10.3109/00016358109162265
Rabago D, Mundt M, Zgierska A, Grettie J (2015) Hypertonic dextrose injection (prolotherapy) for knee osteoarthritis: long term outcomes. Complement Ther Med 3:388–395. doi:10.1016/j.ctim.2015.04.003
Rabago D, Patterson JJ, Mundt M, Zgierska A, Fortney L, Grettie J, Kijowski R (2014) Dextrose and morrhuate sodium injections (Prolotherapy) for knee osteoarthritis: a prospective open-label trial. J Altern Complement Med 5:383–391. doi:10.1089/acm.2013.0225
Rabago DP, Miller DJ, Zgierska AE, Mundt M, Kijowski RX, Jessica B, Patterson JJ (2011) Dextrose prolotherapy for knee osteoarthritis: results of a randomized controlled trial. Osteoarthr Cartil S142–s143. doi:10.1016/S1063-4584(11)60335-X
Rabago D, Patterson JJ, Mundt M, Kijowski R, Grettie J, Segal NA, Zgierska A (2013) Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med 3:229–237. doi:10.1370/afm.1504
Rabago D, Kijowski R, Woods M, Patterson JJ, Mundt M, Zgierska A, Grettie J, Lyftogt J, Fortney L (2013) Association between disease-specific quality of life and magnetic resonance imaging outcomes in a clinical trial of prolotherapy for knee osteoarthritis. Arch Phys Med Rehabil 11:2075–2082. doi:10.1016/j.apmr.2013.06.025
Acknowledgements
We are very grateful to Ms. Parisa Mansoori for helping us with translation of one manuscript.
Author contributions
M.K., M.J., A.J.K. and S.D. screened the bibliographic records. M.K. and M.J. extracted data. M.K. and S.D. assessed risk of bias. L.P. resolved disagreements between authors. M.K. wrote the first version of the manuscript with the help of M.J. All authors contributed to the final version of the systematic review. All authors approved final version of the systematic review.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Role of funding source
The authors did not receive any extramural funding for this study apart from the institutional support of the University of Split School of Medicine and its library services for obtaining manuscripts.
Conflict of interest
The systematic review authors have no conflicts of interest to declare. Conflicts of interest in the included studies were analysed and reported in the manuscript. The majority of the included studies did not report whether there was a conflict of interest or source of funding.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Table 1
(DOCX 24 kb)
Supplementary Table 2
(DOCX 48 kb)
Supplementary Table 3
(DOCX 36 kb)
Supplementary Table 4
(DOCX 37 kb)
Rights and permissions
About this article
Cite this article
Krstičević, M., Jerić, M., Došenović, S. et al. Proliferative injection therapy for osteoarthritis: a systematic review. International Orthopaedics (SICOT) 41, 671–679 (2017). https://doi.org/10.1007/s00264-017-3422-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-017-3422-5